Understanding and applying molecular science is central to effectively treating cancer.
Dr. LaValley utilizes his extensive experience and expertise in integrative cancer treatment and the vast library within PubMed to unlock the anti-cancer benefits of natural product supplements, and re-purposed (off–label) pharmaceutical drugs to create personalized protocols that target cancer at the molecular level – enabling patients to live longer, stronger lives.
Delivering accurate, actionable, researched recommendations for natural supplements at the molecular level is not easy.
Dr. LaValley is one of the world’s most advanced clinical researchers and practitioners in the field. Utilizing the vast knowledge that exists – via the PubMed portal – to unlock the anti-cancer benefits of eating guidelines, natural product supplements, and re-purposed (off–label) pharmaceutical drugs to create personalized treatments for patients with cancer.
His in-depth understanding of molecular biology as well as ability to reference the article and abstract citations in PubMed has allowed him to develop extensive, state-of-the-art, relational, evidence-based databases about the advanced molecular biology of cancer. These databases have helped him build research methodologies for cancer treatments that are designed to be administered in addition to – not instead of – conventional chemotherapy and radiation therapy.
Dr. LaValley’s Poster Presentation for the 11th International Conference of Society for Integrative Oncology in Houston, Texas October 26-28, 2014 on the theme of “Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes.”
“Expanding the anti-cancer toolkit with evidence-based molecular-network-targeting: integrating natural products and off-label pharmaceutical agents in personalized anti-cancer therapy concurrent with, and independent of, radiation and chemotherapy protocols.”
Molecular Integrative Oncology treatment plans are thus far best understood and implemented by various licensed physicians with expertise in Functional Integrative Medicine.
The patchwork quilt of medical and other healthcare licensure laws, regulations and policies provides various healthcare professionals with the scope of practice to receive, review and consider the protocols for their patients and/or clients.
Integrative Medicine physicians who are licensed as MD, DO or DDS can prescribe these treatment options recommended in addition to, not instead of, conventional chemotherapy and radiation therapy:
- re-purposed anti-cancer (off-label) pharmaceuticals, and
- natural product supplements
Depending on each US State or Canadian Province healthcare professional regulations, the following healthcare providers may also be licensed to prescribe the re-purposed off-label anti-cancer pharmaceuticals and natural product supplements as treatment choices:
- licensed Naturopathic Doctors (ND),
- Physician Assistants (PA),
- Nurse Practitioners/Certified Nurse Practitioners (NP/CNP), and
- Registered Pharmacists (RPh)
In USA States and Canadian Provinces where only MDs and DOs are permitted to write prescriptions for pharmaceuticals, other licensed health care professionals are empowered to administer natural product supplements to their patients and clients. Depending on the specific US State or Canadian Province, the following licensed healthcare professionals may be licensed to provided natural product supplement recommendations to their patients or clients:
- Naturopathic Doctors (ND),
- Doctors of Chiropractic (DC),
- Nurse Practitioners/Certified Nurse Practitioners (NP/CNP),
- Registered Dietitians (RD),
- Licensed Dietitians (LD),
- Licensed Acupuncturists (LAc), and
- Certified Nutritional Specialists (CNS).
If you are a licensed physician/practitioner interested in speaking or collaborating with Dr. LaValley, please get in touch with us.
USA 512-794-8907 | Canada 902-275-4555 | info@LaValleyMDProtocols.com
Recent Speaking Events
Sept 22, 23 & 24, 2016: Orlando, FL
Title: Demystifying and simplifying the molecular biology of cancer
Objectives:
- Identify three molecular signaling pathways relevant in cancers
- Identify anti-cancer molecular effect of two molecularly-targeted natural products
- Identify anti-cancer molecular effect of two re-purposed off-label pharmaceuticals
Synopsis: Molecular biology of cancer is a big complex subject which remains poorly understood by many physicians and other healthcare professionals. Only recently has molecular biology become widely taught in medical training. Many doctors haven’t yet had adequate training in the robust evidence-base showing significant molecular anti-cancer effects of natural products and re-purposed off-label pharmaceuticals. This molecularly-targeted evidence-base is readily available and supports the safe and beneficial administration of anti-cancer natural products and re-purposed off-label pharmaceuticals – in addition to – not instead of – conventional oncology treatments (including chemotherapy and radiation therapy). This knowledge is particularly relevant for integrative medicine physicians who treat patients with cancer who are seeking treatment to complement their conventional oncology care. This lecture is designed to give clinicians a relevant, concise and practical overview of the molecular biology of cancer – providing an easy-to-apply intellectual framework to learn and explore relevant molecular biology in treatment of their patients.
